Skip to main content
SpringerLink
Log in

Serum homocysteine level is higher in Behçet’s disease with vascular involvement

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objective

Behçet’s disease (BD) is a multisystemic inflammatory disorder of unknown etiology that is sometimes associated with thrombosis. However, the mechanism of hypercoagulability is not known. In this study, we investigated whether hyperhomocysteinemia, being a well-known risk factor for thrombosis, is also a contributing risk factor to venous and arterial thromboses of BD.

Methods

Forty-five patients with BD and 40 healthy subjects were included in the study. Sixteen patients had vascular involvement. Serum homocysteine levels were determined by fluorescence polarization immunoassay.

Results

In male patients, the frequency of vascular involvement was significantly higher than in females (46.7% vs 13.3%, P<0.05). Serum homocysteine levels were significantly higher in patients with BD than healthy controls (P<0.01), in patients with vascular involvement than those with mucocutaneous involvement (P<0.01) and healthy controls (P=0.001), and in male patients than in female patients (P<0.001). There was no significant difference in homocysteine levels between the BD patients with mucocutaneous involvement and healthy subjects. In multiple regression analysis, serum homocysteine level was independently associated with thrombosis (odds ratio 1.29, P<0.01), but male sex was not.

Conclusions

This preliminary study suggests that elevated serum homocysteine levels may play some role in the development of venous and arterial thromboses in BD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aydıntuğ AO (2001) Vascular manifestations in Behçet’s disease. In: Asherson RA, Cervera R (eds) Vascular manifestations of systemic autoimmune diseases. CRC, Boca Raton, pp 361–373

  2. Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Behçet’s disease and thrombophilia. Ann Rheum Dis 60:1081–1085

    PubMed  Google Scholar 

  3. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407–413

    Article  PubMed  Google Scholar 

  4. Durand P, Prost M, Loreau N, Lussier-Cacan S, Blache D (2001) Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 81:645–672

    CAS  PubMed  Google Scholar 

  5. Dudman NP, Temple SE, Guo XW, Fu W, Perry MA (1999) Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ Res 84:409–416

    CAS  PubMed  Google Scholar 

  6. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759–762

    PubMed  Google Scholar 

  7. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    PubMed  Google Scholar 

  8. Gül A, Özbek U, Öztürk C, İnanç M, Koniçe M, Özçelik T (1996) Coagulation factor V mutation increases the risk of venous thrombosis in Behçet’s disease. Br J Rheumatol 35:1178–1180

    PubMed  Google Scholar 

  9. Gül A, Aslantas AB, Tekinay T, Koniçe M, Özçelik T (1999) Procoagulant mutations and venous thrombosis in Behçet’s disease. Rheumatology 38:1298–1299

    Article  PubMed  Google Scholar 

  10. Hampton KK, Chamberlain MA, Menon DK, Davis JA (1991) Coagulation and fibrinolytic activity in Behçet’s disease. Thromb Haemost 66:292–294

    PubMed  Google Scholar 

  11. Özoran K, Düzgün N, Gürler A, Tutkak H, Tokgöz G (1995) Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet’s disease. Scand J Rheumatol 24:376–382

    PubMed  Google Scholar 

  12. Mader R, Ziv M, Adawi M, Mader R, Lavi I (1999) Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet’s disease. J Rheumatol 26:2404–2408

    PubMed  Google Scholar 

  13. Aksu K, Turgan N, Oksel F, Keser G, Ozmen D, Kitapçioglu G, Gumusdis G, Bayindir O, Doganavsargil E (2001) Hyperhomocysteinaemia in Behçet’s disease. Rheumatology 40:687–690

    Article  PubMed  Google Scholar 

  14. Lee YJ, Kang SW, Yang JI, Choi YM, Sheen D, Lee EB, Choi SW, Song YW (2002) Coagulation parameters and plasma total homocysteine levels in Behçet’s disease. Thromb Res 106:19–24

    Article  CAS  PubMed  Google Scholar 

  15. Korkmaz C, Bozan B, Kosar M, Sahin F, Gulbas Z (2002) Is there association of plasma homocysteine level with vascular involvement in patients with Behçet’s syndrome? Clin Exp Rheumatol 20 [Suppl 26]:S30–S34

  16. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049–1057

    CAS  PubMed  Google Scholar 

  17. Monnerat C, Hayoz D (1997) Homocysteine and venous thromboembolism. Schweiz Med Wochenschr 127:1489–1496

    CAS  PubMed  Google Scholar 

  18. Harpel PC, Zhang X, Borth W (1996) Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J Nutr 126 [Suppl 4]:1285–1289

    Google Scholar 

  19. den Heijer M, Brouwer IA, Bos GMJ, Blom HJ, van der Put NMJ, Spaans AP, Rosendaal FR, Thomas CMG, Haak HL, Wijermans PW, Gerrits WBJ (1998) Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol 18:356–361

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Immunology and Rheumatology, Ankara University Faculty of Medicine, Ankara, Turkey

    Aşkın Ateş, Olcay Aydıntuğ, Ümit Ölmez, Nurşen Düzgün & Murat Duman

  2. Kuzgun sokak, 60/12 A. Ayrancı, 06540, Ankara, Turkey

    Aşkın Ateş

Authors
  1. Aşkın Ateş
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olcay Aydıntuğ
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ümit Ölmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nurşen Düzgün
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Murat Duman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aşkın Ateş.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ateş, A., Aydıntuğ, O., Ölmez, Ü. et al. Serum homocysteine level is higher in Behçet’s disease with vascular involvement. Rheumatol Int 25, 42–44 (2005). https://doi.org/10.1007/s00296-003-0398-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-003-0398-9

Keywords

Search

Navigation